Senti Biosciences, Inc. (SNTI)
1.04
-0.01
(-0.95%)
USD |
NASDAQ |
Dec 31, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Senti Biosciences Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| iBio, Inc. | -21.49M |
| Vor Biopharma, Inc. | -0.244M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.446M |
| Cash from Financing (Quarterly) | 0.124M |
| Free Cash Flow | -50.28M |
| Free Cash Flow Per Share (Quarterly) | -0.3601 |
| Free Cash Flow to Equity (Quarterly) | -8.256M |
| Free Cash Flow to Firm (Quarterly) | -9.446M |
| Free Cash Flow Yield | -288.7% |